Oxidative Phosphorylation is a Metabolic Vulnerability of Endocrine Therapy-Tolerant Persister Cells in ER+ Breast Cancer.
Tau S, Chamberlin MD, Yang H, Marotti JD, Muskus PC, Roberts AM, Carmichael MM, Cressey L, Dragnev CPC, Demidenko E, Hampsch RA, Soucy SM, Kolling FW, Samkoe KS, Alvarez JV, Kettenbach AN, Miller TW.
Tau S, et al. Among authors: yang h.
Cancer Res. 2025 Jan 9. doi: 10.1158/0008-5472.CAN-24-1204. Online ahead of print.
Cancer Res. 2025.
PMID: 39777474